Published on Saturday September 01, 2018
Smooth has started to work on the following projects:
- Our company started to develop medical documentation for a bioequivalence clinical trial in a drug for infectious and inflammatory diseases, conducted by a leading Russian company.
- Smooth is developing medical documentation and EDC for an observational trial of a global company. Our team is also responsible for the training in EDC of the study team.
- Smooth prepares to launch a phase III clinical trial of a biopharmaceutical in osteoporosis.
- Our company launches a bioequivalence trial in arthritis for a global pharmaceutical company.
- Smooth is developing medical documentation for bioequivalence trial of global company.
- Our team is preparing to launch a phase III in schizophrenia for an Asian company. The trial will take place in Russian and Ukraine.
We reached important milestones in the following projects:
- Smooth clinical team has launched a phase II clinical trial in steatohepatitis for a Russian pharmaceutical company.
- Our clinical team opened enrollment in EMA controlled study in pediatrics.